DETOXSCAN.ORG: We welcome our members to review our publication, DetoxScan News; a resource and storytelling digest dedicated to uncovering the truth about toxic exposures and their impact on human health. Our mission is to illuminate the hidden connections between environmental toxins, occupational hazards, implanted materials, and the chronic conditions that affect countless lives. Each issue features educational spotlights, personal health journeys, and expert insights from clinicians, researchers, and advocates leading the charge toward safer, smarter living. From heavy metals and industrial pollutants to the overlooked consequences of medical implants and chemical sensitivities, DetoxScan News curates credible science and first-hand narratives that inspire awareness, accountability, and action. By cataloging current findings and stories from the field, we aim to build a growing community of informed individuals and professionals committed to understanding — and preventing — the toxic triggers behind illness. Knowledge is the first step toward detoxification, healing, and resilience.

Women's Professional Health Network: Formerly known as "The Women's Health Collaborative", our all-volunteer connective network is a resource advisory team- joined together under synergy in support of education, advocacy and sharing of resources in support of the many top health issues of women. Our clinical professionals, researchers and community leaders are joined under the spirit of collaboration and partnership. In October of 2023, our editorial community recently expanded our professional network to bring forth the next generation of visionaries, outreach efforts and resources for Women's Health (including women's cancers and longevity programs) within the Women's Health Digest e-magazine dedicated to public awareness, news and educational information "by women- for women's health"! 

HealthTech Reporter is an independent e-magazine dedicated to exploring cutting-edge developments in medical technology and diagnostic innovation. Published as part of the IPHA program, it features non-commercial reviews of non-invasive medical devices, insights from clinical experts, and in-depth analyses that bridge science, practice, and patient impact. Through research-driven reporting, case studies, and expert interpretation, HealthTech Reporter highlights the real-world performance of emerging technologies, supports educational growth in health care, and advances informed dialogue among clinicians, innovators, and health-tech enthusiasts. Every issue champions evidence-based progress in health-tech adoption and thoughtful evaluation of technologies shaping tomorrow’s care.

ThyroidScan.org champions a transformational approach to thyroid health by merging innovative research, advanced imaging, and patient-centered education. At its core, ThyroidScan highlights cutting-edge clinical initiatives—like explorations into near-infrared and photobiomodulation therapies—to move beyond traditional symptom management and address chronic inflammation, immune dysregulation, and structural damage in autoimmune-driven thyroid disorders. The platform elevates the role of high-resolution ultrasound and multimodal diagnostics, providing clinicians and patients with deeper insight into gland function and disease progression. Through research, advocacy, and education, ThyroidScan.org is redefining how thyroid disorders are detected, understood, and treated in modern endocrine care.

F.A.C.E.S. (Firefighters Against Cancers and Exposures)Firefighting is one of the most noble and demanding professions in our society. Each call requires bravery, selflessness, and a willingness to face life-threatening hazards. Yet behind the heroism lies a sobering truth: firefighters carry a silent and disproportionate health burden. From the constant inhalation of smoke and diesel exhaust, to direct contact with flame retardants, polycyclic aromatic hydrocarbons (PAHs), per- and polyfluoroalkyl substances (PFAS), and other environmental toxins, firefighters are exposed to chemicals that infiltrate the lungs, skin, bloodstream, and even endocrine systems. Over time, these exposures accumulate, raising the risk of thyroid disease, hormone imbalances, metabolic dysfunction, and cancer

Our clinical advisorsI have been privileged to work closely with firefighters. Their resilience is unmatched, yet I have also witnessed how their bodies and minds pay the price for repeated toxic exposures and relentless stress. To serve this population well, we need both conventional medical tools and integrative strategies that target detoxification, hormone balance, and long-term metabolic resilience. This article outlines the unique health issues I encounter in firefighters, followed by evidence-based detoxification programs I have developed—both for daily protection and for post-incident recovery. 

MEET OUR 2026 COLLABORATIVE NETWORK

The AngioInstitute cultivates multiple alliance pathways — each serving a distinct role in the ecosystem.

1. CLINICAL SYNERGISTIC ALLIANCES
A cornerstone of effective private practice is the strength of its referral relationships. Through our clinical partnerships, The AngioInstitute supports the development of trusted co-referral networks that connect physicians and allied health professionals in a coordinated continuum of care.

These partnerships emphasize:
• Mutual confidence and clinical alignment among referring providers
• Timely, appropriate patient routing to ensure early detection and optimal outcomes
• Ethical, patient-first referral practices grounded in shared standards of excellence
• Selective and trusted referral pathways that reinforce the credibility and reputation of participating practices
By fostering exclusive and purpose-driven referral relationships help strengthen private practices while advancing a unified model of care—one in which collaboration is not transactional, but strategic, ensuring that every patient benefits from the right expertise at the right moment in their care journey.

2. RESEARCH & VALIDATION PARTNERSHIPS
Who: Universities, labs, independent researchers, foundations
Purpose:
• Validate emerging therapies and technologies
• Support image-guided treatment evaluation
• Publish findings that elevate standards of care
Value: Positions The AngioInstitute as a bridge between innovation and evidence-based adoption.

3. TECHNOLOGY & INNOVATION PARTNERSHIPS
Who: Medical device manufacturers, imaging tech developers, diagnostic platforms
Purpose:
• Field-test technologies in real-world clinical settings
• Support responsible adoption pathways
• Improve design through practitioner feedback
Value: Ensures innovation is clinically relevant, ethically positioned, and outcome-driven.

4. EDUCATION & PROFESSIONAL DEVELOPMENT PARTNERSHIPS
Who: CME providers, training institutions, professional societies
Purpose:
• Train clinicians in advanced imaging interpretation
• Expand diagnostic literacy
• Promote early detection frameworks
Value: Transforms knowledge into a force multiplier across healthcare systems.

5. ADVOCACY & PUBLIC HEALTH PARTNERSHIPS
Who: Nonprofits, patient advocacy groups, global alliances
Purpose:
• Address health inequities
• Raise awareness of overlooked diseases
• Support screening access and prevention campaigns
Value: Extends the impact of diagnostics beyond clinics into communities and policy.

6. CORPORATE & PHILANTHROPIC PARTNERSHIPS
Who: Foundations, sponsors, mission-aligned enterprises
Purpose:
• Fund research and education initiatives
• Support outreach programs
• Scale public health impact
Value: Aligns resources with responsibility — turning philanthropy into measurable health advancement.



What Makes a The AngioInstitute Partner Different
Partners in the The AngioInstitute network are not vendors, affiliates, or brand ambassadors. They are:
• Trusted collaborators
• Standards-bearers
• Champions of responsible innovation
• Advocates for early detection and prevention
• Educators of both peers and the public
This is a network of conscience as much as competence.

Where These Partnerships Lead
The AngioInstitute partnerships are designed to produce outcomes that extend far beyond individual organizations:
• Earlier detection of disease
• Better validation of emerging therapies
• Stronger interdisciplinary trust
• Smarter adoption of technology
• Broader access to diagnostic education
• A louder voice for prevention and public health
Together, these alliances form a living ecosystem — one that continuously evolves as medicine, technology, and society change.

Our Ethos: The Moral Architecture of Collaboration
At The AngioInstitute, partnership is not defined by contracts alone. Our ETHOS is the moral architecture behind every alliance we build, every referral we make, and every initiative we launch. It is the shared understanding that healthcare is not merely a profession, but a public trust. Our ethos rests on one central belief: Healing is strongest when integrity leads, and collaboration follows.

A Culture of Responsibility
In mental health partnerships especially, responsibility carries deeper weight. We work with professionals who understand that emotional vulnerability deserves not just compassion, but disciplined ethics — clear boundaries, evidence-based practice, and respect for the dignity of every individual.

Our ethos demands that:
• Innovation never outruns responsibility
• Advocacy never overshadows accuracy
• Growth never replaces purpose
Every alliance is evaluated not by how impressive it looks — but by how protective it is of the people we serve.

Trust as a Clinical Asset
Trust is not a soft value at The AngioInstitute — it is a clinical asset. Mental health professionals who partner with us enter a culture where:
• Referrals are made with discernment, not convenience
• Imaging is applied with humility, not spectacle
• Patients are seen as whole lives, not case files
This ethos transforms collaboration from a network into a community of conscience — where psychiatrists, therapists, coaches, and diagnosticians share not only tools, but standards.

The Ethics of Integration
Integrative care can be powerful — and dangerous — if not guided by principle. Our ethos protects against this by insisting that every interdisciplinary bridge be built on:
• Transparency in scope and claims
• Respect for professional autonomy
• Clear communication with patients
• Shared accountability for outcomes
Mental health is not an accessory to medicine — and medicine is not a substitute for therapy. Our ethos honors the distinct role of every discipline, while uniting them around the patient’s full reality.

Leadership through Character
Working with The AngioInstitute team means aligning with leadership that values:
• Courage to question trends
• Discipline to demand evidence
• Humility to learn across fields
• Resolve to protect ethical standards
This ethos gives mental health partners more than collaboration — it gives them credibility in an era where trust is fragile.

A Shared Ethical Future
In a time when healthcare faces fragmentation, commercialization, and burnout, The AngioInstitute chooses a different path: A path where ethos precedes expansion, where values shape velocity, and where partnerships exist not just to grow organizations -but to protect the soul of care itself. This is the foundation of every mental health alliance we build.

Closing Statement
The AngioInstitute does not build partnerships for optics. We build them for impact. Our alliance philosophy recognizes that the future of healthcare belongs to those who work together — across disciplines, across institutions, and across borders — to raise the standard of how disease is detected, understood, and prevented. Through synergy, integrity, and shared mission, The AngioInstitute and its partners are shaping not just better diagnostics — but a better model of collaboration in medicine.

Presentation: Healing After Covid-19: Impacts in Pediatric Medulloblastoma

By: NOELLE CUTTER, Ph.D, Assoc. Professor of Biology & Chemistry - Molloy University / NY Cancer Resource Alliance
In collaboration with NYCRA scientific panel experts: ROBERT BARD, MD and ROBERTA KLINE, MD

This video presentation is part 2 of Dr. Noelle Cutter's 2021 presentation on the Impact of Covid-19 in Pediatric Medulloblastoma. It includes a collaboration with Dr. Robert Bard (cancer imaging specialist) and Dr. Roberta Kline (leading genomics advisor). Medulloblastoma (MB) is a devastating illness and is the most common pediatric malignant brain tumor. It is predominantly treated with cytotoxic and nontargeted approaches. Survivors of MB also suffer from severe treatment-related effects of radiation and chemotherapy keeping mortality rate high.

Over the last several years, remarkable technological breakthroughs have facilitated the molecular characterization of multiple tumor types, provided new insights into the genetic basis of these cancers, and prompted innovative strategies that are changing the management paradigm in pediatric neuro-oncology. Genomic tests have begun to affect medical decision making in several ways, from delineating histopathologically similar tumor types into distinct molecular subgroups that correlate with clinical characteristics, to guiding the addition of novel therapeutic agents for patients with high-risk or poor-prognosis tumors, or alternatively, reducing treatment intensity for those with a favorable prognosis. However, the impact of COVID19 may have on the pediatric population, and the management of children with cancer, remains unclear and poorly documented. (See complete video)

OPTICSCAN: NEURO-TESTING FOR CONCUSSION METRICS

A new study is underway at THE BARD CANCER CENTER IN NYC. Dr. Robert Bard and a local research team combines the latest biometric scanning advantages of transcranial DOPPLER imaging, hemodynamic ULTRASOUND scanning (of the retinal, basilary and temporal arteries) and the integration of BIOFEEDBACK technology for a special research study. This neuro-scan review establishes (1) a cross-comparative study between the technologies and (2) a multi-modality screening & monitoring protocol to record post-concussion and neurodegenerative disorders.

THEORIES AND OBJECTIVES: Neuroscanning aims to identify any/all biometrics recorded through the use of standard and approved medical imaging technologies (like 3D Doppler Ultrasound). Use of noninvasive diagnostic tools used in this study are selected based on their anticipated ability to collect baseline data. It is also often used as comparative assessment of any therapeutics or response from outside stimulation.

SELECTED AREAS SCANNED WITH ULTRASOUND: Autoregulation of the circulatory system is controlled by several homeostatic mechanisms including the autonomic nervous system, which is believed to be a mechanism by which meditation alters cardiovascular function. As such, evaluating blood vessel flow and function aligns with studying the body’s effects under a meditative state. According to Dr. Robert Bard, the areas of the body scanned with ultrasound are key areas that have the highest probability of response and reaction from a device that claims to promote bringing the subject into a meditative state. The chosen target scan areas (Basilar Artery, Eye/Optic Nerve, Temporal Artery and Radial Artery) are identified as key zones for hemodynamic study, showing the most effective areas for studying blood flow.

Research Review:

Neurodegenerative Diseases and the Vascular System
by: Jay Lombard, D.O / Robert Bard, MD

The notion that neurological diseases are preventable will evolve over time, as has already been seen in with a greater understanding of cardiovascular disease. The field of cardiology has become much more proactive in addressing cardiovascular health, where identifiable and modifiable risk factors can be assessed by clinicians and used to prevent or address heart and vascular disease earlier on in the process. This is directly applicable to neurological diseases, as there is a growing recognition that vascular factors play a critical role in brain health.

Now that radiologists are using Doppler blood flow to examine eye disease, including systemic diseases (including Diabetes, Brain tumors, heart disease, sickle cell disease etc) that affect the eye, we are hopeful that the ophthalmologic and neurological communities will start using this noninvasive technology as well to improve noninvasive and more rapid treatment of potential eye disorders, such as cancers of the eye, diabetes and glaucoma. Another future use will be to correlate the effect of decreased vascular pulsation in the production of cerebrospinal fluid that is removed by the cleansing glymphatic system is postulated as a contributing factor in degenerative neuromuscular disease.

Global Research Alliance Targeting the MENTAL HEALTH CRISIS

The Coronavirus Pandemic scorched the global community with unprecedented health effects on its countless victims (from cardiopulmonary issues to neurological damage etc). Mitigating the rise in infection and mortality rates called for a 'borderless' collective of scientists and medical experts to form a mass research initiative. This joint effort brought us the worldwide vaccine development, prevention & prophylactic solutions, geo-social intervention and diagnostic innovations. This includes post-infection disorders (long haul) are the next major concern, demanding quantifiable research and treatment protocols.

From economic stresses to social isolation to fears of infection from a deadly virus, SARS-CoV-2 has also driven an unprecedented MENTAL HEALTH crisis. Since mid-2020, national news and mental health professionals reported an unusually high rate of substance abuse, depression, suicide cases and a major spike in public violent (anger and rage-driven) crimes [1] [2] [3]. In March of 2021, the AngioFoundation formed an integrative coalition of mental health and clinical experts to review the top innovations and modalities to focus on this pandemic related list of mental health issues.

"The strategy behind the use of multiple protocols to battle any health issue or crisis has always been the most effective solution (historically) in medical care," states Dr. Robert Bard, cancer diagnostic expert. "Decades in cancer care has proven that there is NO ONE ANSWER TO CANCER... meanwhile, having multiple sets of options within integrative medicine helps to provide the best chance of success. We apply this concept towards depression, PTSD or even suicidal tendencies... we are now seeing breakthroughs in areas like medical imaging to track and quantify physiological and neurological evidence aligned with these disorders. These innovations can only add a new level of detection, data measurement and tracking confirmation to support patient care professionals, and aid in the treatment (and reversal) of our global mental health crisis."

Cranial Scan & Neuro-Imaging of PTSD

Emotional traumas and stress influencers are scientifically aligned with anxiety, depression, behavioral disorders, drug/alcohol abuse and a wide list of physiological health issues. These symptoms are typically diagnosed by mental health professionals through observational science and behavioral analysis. But within the past 15 years, global advancements in transcranial imaging pioneered the ability to detect trauma-related issues in the brain through neurological imaging. Now, neurological stress can be identified clinically by monitoring chronic imbalance and changes in the neurochemical structure (or circuitry). The shift in memory performance - specifically the hippocampus and the medial prefrontal cortex is one indicator of this imbalance whereby a stressful event can show images with signs of neuronal dysfunction.

Neuro-imaging measures brain thought activity which has known chemical tissue changes by observing the alterations in capillary blood vessels in the retina located in close proximity to the main emotional center of the anterior brain. Functional MRI (fMRI) is currently used to show brain chemical changes with cognitive commands such as “death vs freedom.” Most recognizable patterns with suicide occur in the anterior cingulate cortex of the brain which lies directly behind the globe and is vascularized by orbital branches of the anterior cerebral artery. Functional near infrared imaging (fNIR) devices show changes in brain oxygenation linked to suicide.

Another imaging innovation is the TRANSCRANIAL DOPPLER (TCD) - a type of sonogram that is a non‐invasive, non‐ionizing, inexpensive, portable and safe technique that uses a pulsed Doppler transducer for assessment of the blood flow in the anterior cerebral arterial circulation. This technology has been used to evaluate intracranial steno‐occlusive disease, subarachnoid hemorrhage, and extracranial diseases (including carotid artery disease and subclavian steal syndrome), detection of microembolic signals and acute strokes. The Transcranial Doppler has been used to examine the mean speed of blood circulation of patients to validate and monitor treatment efficacy by tracking cranial blood vessels and vertebrobasilar flow vasospasm.

Psychoanalysis and Optical Brain Imaging in vivo

Another device used by imaging specialists to detect mental distress is through an EYE SONOGRAM or Real Time Sonofluoroscopy of the orbital soft tissues of the eyes. This process is performed in multiple scan planes with varying transducer configurations and frequencies. Power and color Doppler use angle 0 degrees and PRF at 0.9 at the optic nerve head. 3D imaging of optic nerve and carotid, central retinal arteries and superficial posterior ciliary arteries performed in erect position before & after verbal communication and orbital muscle tissue contractions may be observed as a precursor to visual changes in facial expression. Retinal arterial directional flow is also measured with peak systolic and diastolic values. Bulging of the optic nerve head is checked as increased intracranial pressure may be demonstrable in this condition. Other innovations such as the TRANSORBITAL DOPPLER, 3D/4D VESSEL DENSITY HISTOGRAM and the RETINAL OCT (optical coherence tomography) are also being explored in the pursuit of studying brain performance through the eyes. An expanded review on these solutions will be available in part 2 of this report.

Suicide and PTSD

Considerable research has reported a strong connection between significant forms of trauma and suicides or similar behaviors. Moreover, additional claims indicate an elevated number of cases from individuals with mental illness. With military Veterans, for example, combat-related traumas have been closely monitored to indicate a heavy preoccupation to self-inflict injury as a means of engaging recurrent nightmares, relenting negativity, high emotions of high anxiety, anger or guilt acquired from times of active duty. These cases are often scalated by clinical depression, substance abuse and suppressed or hidden emotions that result in uncontrollable reactions. [1]

Suicide rates have been rising in nearly every state, according to the latest Vital Signs report by the Centers for Disease Control and Prevention (CDC). In 2016, nearly 45,000 Americans age 10 or older died by suicide. Suicide is the 10th leading cause of death and is one of just three leading causes that are on the rise. [2]. Approximately 23% of people who had experienced a physical assault had also attempted suicide at some point in their life. These rates of suicide attempts increased considerably among people who had experienced multiple incidents of sexual (42.9%) or physical assault (73.5%). [3] Further, some cognitive styles of coping such as using suppression to deal with stress may be additionally predictive of suicide risk in individuals with PTSD. [4]

1) The Major Occupational Hazard of Post Traumatic Recall - Journal of Modern Healing
2) Suicide rates rising across the U.S.- CDC.gov
3) The Connection Between PTSD & Suicide: VeryWellMind.com
4) US Dept. of Veterans Affairs: National Center for PTSD: How Common is Suicide

Occupational Hazard of Post Traumatic Recall
By: JESSICA A. GLYNN, LMSW, CPC, CEC

High risk professions like law enforcement, military service, healthcare and emergency response are known to have exposure to some of the most extreme levels of trauma - both physically and psychologically. They range in effects from manageable symptoms to crippling disorders. Over time, most people overcome disturbing or traumatic experiences and continue to work and live their lives. But others who get affected by traumatic experiences may trigger a reaction that can last for months or even years. This is called Post-traumatic Stress Disorder, or PTSD. Proportionately, studies have shown a lower percentage of retirees from such challenging careers acquire PTSD (from 15-20%) while an estimated 30-40% who suffer from PTSD associated symptoms go undetected or do not register as full cases. A larger percentage ‘on the job’ might be able to maintain the expected work standards throughout their career and even make it to retirement without visible signs. But “POST traumatic recall” leading to fully blown PTSD occurs when repeated exposure to trauma compounds on the tolerance capacity that eventually, one’s coping ability collapses. The individual may feel stages of grief, depression, anxiety, guilt or anger from uncontrollable issues like recurring flashbacks and nightmares.

Enduring trauma is different and unique for everyone. Some cases are event-specific (having intense auditory impact or visual intensity of a terrifying event) while other cases are contingent upon the tolerance of an individual. There are people who are more emotionally expressive than others- and that might help with if they talk about the trauma that they've been through. A latent emotional disorder like PTSD symptoms can come out over time just like anything that is suppressed or repressed. It could take some time for somebody who came back from combat or a first responder who has been in a traumatic event to show signs of disturbance. They could be holding it in and repeatedly thinking about it privately (or ruminating over it) allowing the disturbing memories to get more intense by the day. This can often be a coping mechanism- protecting themselves from dark or negative feelings for a while, but eventually it builds up and can become symptomatic like flashbacks and anxiety, then leading to an eventual explosion. Meanwhile, some people just have flashbacks right after the experience because of the way that everybody's brain processes differently. Others obsess over thoughts that keep popping up over and over again. It really just depends on the person.

Disclaimer & Copyright Notice: The materials provided on this website are copyrighted and are the intellectual property solely of the publishers/producers (The AngioFoundation / the NY Cancer Resource Alliance /  IntermediaWorx inc). It is provided to you solely for your own personal, non-commercial use and not for purposes of resale, distribution, public display or performance, or any other uses by you in any form or manner whatsoever. Unless otherwise indicated on this Internet web site, you may display, download, archive, and print a single copy of any information on this Internet web site, or otherwise distributed from us for such personal, non-commercial use.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages, in the Terms of Use or in the Additional Information section of our Site (which his incorporated herein by reference).The publishers/producers of this website and the contents of this website such as videos, graphics, text, and other materials published are for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 911 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.